Data Monitoring Committee: "A Phase 3 randomized, multicenter, multinational, double-blinded studycomparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) andalglucosidase alfa in treatment-naive patients with late

Project: Research project

Description

Data Monitoring Committee: "A Phase 3 randomized, multicenter, multinational, double-blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment-naive patients with late
StatusActive
Effective start/end date2/15/1912/31/20

Funding

  • SANOFI-AVENTIS US

Fingerprint

Clinical Trials Data Monitoring Committees
Safety
Therapeutics
human GAA protein